共 50 条
- [47] [177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer LANCET ONCOLOGY, 2018, 19 (08): : E372 - E372
- [49] Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617 European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2322 - 2327